Nextech has been an exceptional partner with deep oncology expertise and a long-term investment perspective. Beyond providing critical financial firepower through multiple rounds, their strategic guidance reflects a genuine understanding of our science and commitment to our mission of overcoming resistance in cancer.
Jacob M. Chacko, MD
CEO & President
ORIC Pharmaceuticals